Related Experiment Video
Updated: May 12, 2026

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Recurrent Metastatic Malignant Wolffian Tumour: A Rare and Aggressive Clinical Course
Junzhe Zhao1, Yen Ching Yeo2, Yash B Boricha3
1Obstetrics and Gynaecology, Duke-NUS Medical School, Singapore, SGP.
Abstract:
Wolffian tumours (female adnexal tumours of probable Wolffian origin, FATWO) are rare mesonephric duct-derived neoplasms with variable malignant potential and challenging diagnosis. A 68-year-old woman underwent complete resection for a left tubo-ovarian mass and was diagnosed with a localised Wolffian tumour with malignant potential. After 22 months of surveillance, she re-presented with malignant ascites and extensive peritoneal dissemination showing anaplastic transformation and underwent cytoreductive surgery. Adjuvant chemotherapy was poorly tolerated and ineffective, with rapid progression despite treatment, leading to best supportive care. This case highlights the diagnostic complexity and potential aggressive behaviour of malignant Wolffian tumours, the limited efficacy and tolerability of chemotherapy in advanced disease, and the need for early integration of palliative care when disease becomes refractory.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
